| Jun 8, 2023 |
Jun 9, 2023 |
Krystal Biotech, Inc.
|
Director |
Sell |
16.3
|
-50,000
|
-31.77%
|
✗
|
$6.4M |
| May 19, 2023 |
May 23, 2023 |
Krystal Biotech, Inc.
|
Director |
Sell |
10.0
|
-50,000
|
-24.11%
|
✓
|
$4.8M |
| May 9, 2023 |
May 11, 2023 |
Krystal Biotech, Inc.
|
Director |
Sell |
23.8
|
-17,100
|
-7.62%
|
✓
|
$1.6M |
| Apr 19, 2023 |
Apr 21, 2023 |
Krystal Biotech, Inc.
|
Director |
Sell |
35.0
|
-7,900
|
-3.40%
|
✓
|
$713.5K |
| Dec 10, 2021 |
Dec 14, 2021 |
Krystal Biotech, Inc.
|
Director |
Sell |
16.3
|
-100,000
|
-27.30%
|
✗
|
$7.1M |
| Sep 17, 2021 |
Sep 17, 2021 |
Tyra Biosciences, Inc.
|
10% Owner |
Buy |
92.5
|
+156,250
|
3.98%
|
✗
|
$2.5M |
| Aug 29, 2019 |
Sep 3, 2019 |
Krystal Biotech, Inc.
|
Director |
Sell |
17.5
|
-88,684
|
-19.49%
|
✗
|
$4.1M |
| Jan 18, 2018 |
Jan 22, 2018 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-45,126
|
-6.74%
|
✗
|
$497.7K |
| Sep 22, 2017 |
Sep 25, 2017 |
Krystal Biotech, Inc.
|
Director |
Buy |
100.0
|
+200,000
|
153.15%
|
✗
|
$2M |
| Mar 21, 2017 |
Mar 23, 2017 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
15.0
|
-350,000
|
-20.38%
|
✗
|
$16M |
| Dec 28, 2015 |
Dec 30, 2015 |
Evofem Biosciences, Inc.
|
Other |
Sell |
17.5
|
-797,987
|
-37.33%
|
✗
|
$1.2M |
| Dec 15, 2015 |
Dec 17, 2015 |
Evofem Biosciences, Inc.
|
10% Owner |
Sell |
20.0
|
-529,261
|
-19.84%
|
✗
|
$762.1K |
| Apr 14, 2015 |
Apr 14, 2015 |
KalVista Pharmaceuticals, Inc.
|
10% Owner |
Buy |
100.0
|
+877,500
|
25.32%
|
✗
|
$4.4M |
| Nov 25, 2014 |
Nov 25, 2014 |
Evofem Biosciences, Inc.
|
Director |
Sell |
27.5
|
-79,286
|
-0.76%
|
✗
|
$1.1M |
| Oct 21, 2014 |
Oct 21, 2014 |
Esperion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+500,000
|
24.36%
|
✗
|
$10M |
| Jul 1, 2013 |
Jul 1, 2013 |
Esperion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+235,714
|
12.98%
|
✗
|
$3.3M |
| Feb 16, 2011 |
Feb 18, 2011 |
TALPHERA, INC.
|
10% Owner |
Buy |
100.0
|
+680,000
|
32.15%
|
✗
|
$3.4M |